The Modulation of CD40 Ligand Signaling by Transmembrane CD28 Splice Variant in Human T Cells

18Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

Abstract

The role of CD40 ligand (CD40L)/CD40 signaling in T cell-dependent B cell differentiation and maturation has been amply documented. The mechanism of CD40 signaling in B cells has been well established, whereas the signaling mechanism of CD40L in T cell costimulation remains unknown. In this study we show that CD28i, a transmembrane splice variant of CD28 costimulatory receptor, complexes with CD40L in human T cells. The cross-linking of CD40L resulted in the coendocytosis of CD28i with CD40L. The tyrosine phosphorylation of CD28i followed the cross-linking of CD40L, and the overexpression of CD28i augmented the c-Jun NH2-terminal kinase, p21-activated kinase 2, and nuclear factor βB activation. These data indicate that CD28i, by functioning as a signaling adaptor, transduces CD40L signaling as well as CD28 signaling in human T cells.

Cite

CITATION STYLE

APA

Mikolajczak, S. A., Ma, B. Y., Yoshida, T., Yoshida, R., Kelvin, D. J., & Ochi, A. (2004). The Modulation of CD40 Ligand Signaling by Transmembrane CD28 Splice Variant in Human T Cells. Journal of Experimental Medicine, 199(7), 1025–1031. https://doi.org/10.1084/jem.20031705

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free